American Heart Journal

Papers
(The H4-Index of American Heart Journal is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Information for Readers122
Response to letters-to-the-editor for publication: “Defect-free care trends in the Paul Coverdell National Acute Stroke Program (PCNASP), 2008-2018. American Heart Journal. 2021;232:177-184. doi:10.1095
Information for Readers84
Non-Adherence to Antihypertensive Medications Among the US Population: A Pooled Analysis of 22 Million Patients77
Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER69
In vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging68
Editorial Board65
Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial65
Accuracy of Diagnosing Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and DKA-HHS: The Significance for Cardiac Function60
Heart failure and nocturnal hypoxemic burden, the connection is getting closer and closer58
Association of Increased Fructose Consumption with Atrial Fibrillation Symptoms58
Differences in Clinical Outcomes Between Non-Obese Caucasian and African American Populations Who Have Diabetes, A Nation-Wide Study46
Table of Contents46
Table of Contents42
Diagnostic performance of a novel automated CT-derived FFR technology in detecting hemodynamically significant coronary artery stenoses: A multicenter trial in China40
The trial to assess chelation therapy 2 (TACT2): Rationale and design36
COMPARE LAAO: Rationale and design of the randomized controlled trial “COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at hig36
Nationwide Utilization of Danish Government Electronic letter system for increasing inFLUenza vaccine uptake (NUDGE-FLU): Study protocol for a nationwide randomized implementation trial35
Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial33
Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial32
Differences in incident and recurrent myocardial infarction among White and Black individuals aged 35 to 84: Findings from the ARIC community surveillance study32
The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism31
Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings30
Risk of delayed percutaneous coronary intervention for STEMI in the Southeast United States30
Cardiac rehabilitation availability and characteristics in Latin America and the Caribbean: A Global Comparison29
Evaluation of Huawei smart wearables for detection of atrial fibrillation in patients following ischemic stroke: The Liverpool-Huawei stroke study28
Physician responses to apple watch-detected irregular rhythm alerts27
Rheumatoid Arthritis and the Connection with Cardiovascular Disease Mortality27
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial27
Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded e27
Ambulatory inotropic therapy: To what end?27
0.11667895317078